USask researchers seek to develop new breast cancer treatments

Improving patient’s cancer treatments and minimizing side effects is the focus of new research at the University of Saskatchewan (USask) which aims to explore an innovative and potentially life-changing treatment targeting the most aggressive form of breast cancer.

A University of Saskatchewan (USask)-led project with the support of the Saskatchewan Network Environments for Indigenous Health Research (SK-NEIHR) puts Métis stories front and centre.

The Saskatoon philanthropist, who died on March 13, 2024, at the age of 91, was bestowed with an honorary degree in 2007 for his many contributions to the University of Saskatchewan and to organizations across the province.

Telemiracle 48 earned more than $6.1 million, thanks in part to contributions from students at the College of Agriculture and Bioresources at the University of Saskatchewan (USask).

The multi-faceted project involved experiential learning for local high school and University of Saskatchewan (USask) students.

The University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization (VIDO) has been selected to join the North Atlantic Treaty Organization’s (NATO) Defence Innovation Accelerator for the North Atlantic (DIANA) program. VIDO is one of 13 new Canadian test centres chosen to be part of the network—and the only centre with biotechnology as its main focus.

University of Saskatchewan (USask) researchers have received $17 million from the Canada Foundation for Innovation (CFI) fund in support of the HAWC (High-altitude Aerosols, Water vapour and Clouds) mission. This will place USask at the forefront of space innovation and has the potential to revolutionize the way we understand and address climate change.